CLOVER CORPORATION LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.51 AUD | -1.92% |
|
-1.92% | -38.18% |
| Mar. 20 | Clover Swings to Loss in H1 FY24; Shares Down 16% | MT |
| Mar. 19 | Clover Corporation Limited Reports Earnings Results for the Half Year Ended January 31, 2024 | CI |
| Sales 2024 * | 64.64M 41.87M | Sales 2025 * | 75.37M 48.81M | Capitalization | 85.17M 55.17M |
|---|---|---|---|---|---|
| Net income 2024 * | - 0 | Net income 2025 * | 3M 1.94M | EV / Sales 2024 * | 1.41 x |
| Net Debt 2024 * | 5.98M 3.87M | Net Debt 2025 * | 2.48M 1.61M | EV / Sales 2025 * | 1.16 x |
| P/E ratio 2024 * |
142
x | P/E ratio 2025 * |
24.4
x | Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
1.64% | Free-Float | 83.31% |
More Fundamentals
* Assessed data
More news
Latest transcript on Clover Corporation Limited
| 1 day | -1.92% | ||
| 1 week | -1.92% | ||
| Current month | +5.15% | ||
| 1 month | -7.27% | ||
| 3 months | -39.29% | ||
| 6 months | -49.00% | ||
| Current year | -38.18% |
1 week
0.51
0.53
1 month
0.460.57
Current year
0.460.85
1 year
0.461.36
3 years
0.461.98
5 years
0.463.31
10 years
0.143.31
| Managers | Title | Age | Since |
|---|---|---|---|
Peter Davey
CEO | Chief Executive Officer | - | 14-11-10 |
Andrew Allibon
DFI | Director of Finance/CFO | - | 21-05-05 |
David Pierotti
COO | Chief Operating Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 15-06-30 | |
Ian Glasson
BRD | Director/Board Member | - | 17-01-31 |
Graeme Billings
BRD | Director/Board Member | 68 | 13-05-13 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 0.51 | -1.92% | 22 375 |
| 24-04-22 | 0.52 | -0.95% | 16,512 |
| 24-04-19 | 0.525 | +2.94% | 9,600 |
| 24-04-18 | 0.51 | -2.86% | 8,695 |
| 24-04-17 | 0.525 | +2.94% | 144,459 |
Delayed Quote Australian S.E., April 23, 2024 at 02:10 am EDT
More quotes
Clover Corporation Limited is an Australia-based company, which is focused on technology, new product development and commercialization. The Company's microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formula, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company's product offerings include docosahexaenoic acid (DHA) Oils and DHA Powders. Its DHA Oils include Nu-Mega HiDHA tuna oils and Ocean Gold. Its products are sourced from tuna oil. Its DHA Powders include Nu-Mega Driphorm powders and Nu-Mega Driphorm HA. Nu-MegaDriphorm powders utilize MicroMax technology to microencapsulate nutritional oils. Nu-Mega Driphorm powders are used in a range of infant formulas, follow-on formulas, growing up milks and food applications. Its Nu-Mega Driphorm HA is used for non-dairy applications.
Sector
Food Processing
Calendar
2024-09-18
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.52
AUD
Average target price
0.6
AUD
Spread / Average Target
+15.38%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -38.18% | 55.89M | |
| +5.54% | 7.44B | |
| -2.62% | 7.21B | |
| +0.22% | 5.8B | |
| -8.57% | 3.65B | |
| -14.92% | 3.29B | |
| -15.31% | 1.16B | |
| +12.72% | 940M | |
| -38.83% | 907M | |
| -16.94% | 851M |
- Stock Market
- Equities
- CLV Stock
